ReviewDrug design, development and therapy2024

Dupilumab Treatment in Pediatric Patients Aged 6-11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled: A Review.

Michael J Cork et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.